Spots Global Cancer Trial Database for cyberknife
Every month we try and update this database with for cyberknife cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| On the Cyberknife Dose Fraction of Liver Cancer Treatment | NCT03295500 | CyberKnife Radi... | Dose fraction f... | 30 Years - 80 Years | Beijing 302 Hospital | |
| SBRT Plus Pembrolizumab and Trametinib for Pancreatic Cancer | NCT02704156 | Pancreatic Canc... | Cyberknife plus... Cyberknife plus... | 18 Years - | Changhai Hospital | |
| Non-inferiority Study of Unresectable Hepatocelluar Carcinoma Receiving Stereotactic Radiotherapy Combined With Hepatic Arterial Chemoembolization Compared With Conversion Hepatectomy | NCT05057104 | Hepatocellular ... Conversion | 18 Years - 80 Years | Beijing 302 Hospital | ||
| CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer | NCT01985828 | Prostate Adenoc... | CyberKnife Androgen Depriv... Intensity Modul... | 18 Years - | Advocate Health Care | |
| Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002) | NCT02707328 | Pancreas Cancer Pancreatic Canc... Adenocarcinoma ... Pancreas Adenoc... Pancreatic Aden... | Gemcitabine nab-paclitaxel CyberKnife | 18 Years - | The Cooper Health System | |
| Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Radiosurgery | NCT01766492 | Prostate Cancer Localized Malig... | Stereotactic Bo... | 18 Years - 99 Years | Georgetown University | |
| CyberKnife for Unresectable Renal Tumors | NCT00807339 | Renal Cancer | Stereotactic ra... CyberKnife Robo... | 18 Years - 95 Years | Beth Israel Deaconess Medical Center | |
| CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution | NCT00643994 | Prostate Cancer Prostatic Cance... Prostate Neopla... Prostatic Neopl... Cancer of the P... | CyberKnife Ster... | 18 Years - | Accuray Incorporated | |
| Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002) | NCT02707328 | Pancreas Cancer Pancreatic Canc... Adenocarcinoma ... Pancreas Adenoc... Pancreatic Aden... | Gemcitabine nab-paclitaxel CyberKnife | 18 Years - | The Cooper Health System | |
| SBRT/RT in Oligometastatic Stage IV NSCLC | NCT05647590 | Non Small Cell ... | Chemotherapy Radiotherapy (R... Maintenance che... | 18 Years - 85 Years | University Hospital Ostrava | |
| Pulmonary Interstitial Lymphography in Early Stage Lung Cancer | NCT01188486 | Lung Cancer Lung Cancer Non... Lung Cancer Sma... Mesothelioma | Stereotactic Bo... Computed Tomogr... Cyberknife Trilogy True Beam Iohexol Iodixanol | 18 Years - | Stanford University | |
| Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer | NCT00840749 | Non-small Cell ... | CyberKnife Ster... Surgery | 18 Years - | Accuray Incorporated | |
| Focused Stereotactic Radiation Treatment of Prostatic Adenocarcinoma | NCT03284151 | Prostate Cancer | Cyberknife | - | Centre Francois Baclesse, Luxembourg | |
| A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate Tumors | NCT02225262 | Prostate Cancer Cancer of the P... Prostate Neopla... | CyberKnife Radi... | 21 Years - | Community Cancer Center, Normal, Illinois | |
| Evaluation of CyberKnife Stereotactic Radiotherapy in Prostate Cancer | NCT02016248 | Prostate Cancer | Stereotactic Ab... Stereotactic Ab... | 18 Years - | MemorialCare Health System | |
| Multi-Institutional Registry for Prostate Cancer Radiosurgery | NCT01226004 | Prostate Cancer... Prostate Cancer... | 18 Years - 90 Years | RPCR, Inc. | ||
| Multi-Institutional Registry for Prostate Cancer Radiosurgery | NCT01226004 | Prostate Cancer... Prostate Cancer... | 18 Years - 90 Years | RPCR, Inc. | ||
| Feasibility Study of Stereotactic Body Radiotherapy for Early Breast Cancer | NCT02065960 | Breast Neoplasm | Stereotactic bo... | 70 Years - | Juravinski Cancer Center | |
| Stereotaxic Irradiation of Hepatocellular Carcinoma | NCT01165346 | Hepatocellular ... | Fiducials CyberKnife | 18 Years - | Centre Oscar Lambret | |
| CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer | NCT02070952 | Prostate Cancer | CyberKnife Ster... | 18 Years - | Riverside Community Hospital, California | |
| A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer | NCT02707315 | Pancreas Cancer Pancreatic Canc... Adenocarcinoma ... Pancreas Adenoc... Pancreatic Aden... | Gemcitabine Stereotactic Ra... | 18 Years - | The Cooper Health System | |
| A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer | NCT02707315 | Pancreas Cancer Pancreatic Canc... Adenocarcinoma ... Pancreas Adenoc... Pancreatic Aden... | Gemcitabine Stereotactic Ra... | 18 Years - | The Cooper Health System | |
| Stereotactic Radiosurgery for Soft Tissue Sarcoma | NCT02706171 | Soft Tissue Sar... | CyberKnife | 18 Years - | The Cooper Health System | |
| Cyberknife Radiosurgery Boost for Hilar Cholangiocarcinoma (Klatskin Tumor) | NCT00630890 | Cholangiocarcin... Klatskin Tumor Biliary Tract C... | External beam r... | 18 Years - | University of California, San Francisco | |
| A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma | NCT01890590 | Renal Cell Carc... | CyberKnife | 18 Years - | Dana-Farber Cancer Institute | |
| Stereotactic Radiotherapy for Brain Metastases | NCT03286023 | Metastasis Brai... | stereotactic ra... | 18 Years - | Centre Francois Baclesse, Luxembourg | |
| Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma | NCT01327521 | Carcinoma, Hepa... | CyberKnife TACE CT Contrast doxorubicin Epirubicin 5-fluorouracil Mitomycin C Gemcitabine Cisplatin SMANCS | 18 Years - | Stanford University | |
| Transarterial Chemoembolization (TACE) vs. CyberKnife for Recurrent Hepatocellular Carcinoma (HCC) | NCT01318200 | Recurrent Hepat... | Transarterial C... CyberKnife SBRT | 18 Years - | Accuray Incorporated | |
| Dose Escalation Study of CyberKnife® SBRT Boost for Patients With Unresectable Locally Advanced Pancreatic Cancer | NCT01872377 | Pancreatic Carc... | CyberKnife® Ste... | 19 Years - 80 Years | Ottawa Hospital Research Institute | |
| Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR) | NCT01573702 | Non Small Cell ... | Stereotactic Ra... Erlotinib | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Stereotaxic Irradiation of Hepatocellular Carcinoma | NCT01165346 | Hepatocellular ... | Fiducials CyberKnife | 18 Years - | Centre Oscar Lambret | |
| A Multi-Institutional Registry for CyberKnife Stereotactic Accelerated Partial Breast Irradiation (CK-SAPBI) | NCT02457117 | Breast Cancer | CyberKnife Ster... | 50 Years - 99 Years | Georgetown University | |
| The CyberChallenge Trial How Much is Too Much - What is the Role of Cyberknife Radiosurgery in Patients With Multiple Brain Metastases? | NCT05378633 | Brain Metastase... Nsclc | SRS Whole Brain Rad... | 18 Years - | University Hospital Heidelberg | |
| A Study of Gemcitabine and Cyberknife Radiation Therapy for Pancreatic Cancer | NCT01051284 | Pancreatic Canc... | Cyberknife radi... | 18 Years - | Georgetown University | |
| Non-inferiority Study of Unresectable Hepatocelluar Carcinoma Receiving Stereotactic Radiotherapy Combined With Hepatic Arterial Chemoembolization Compared With Conversion Hepatectomy | NCT05057104 | Hepatocellular ... Conversion | 18 Years - 80 Years | Beijing 302 Hospital | ||
| CyberKnife for Prostate Cancer Patients Aged 70 y or More | NCT03235557 | Prostate Cancer | 70 Years - | Centre Francois Baclesse, Luxembourg | ||
| Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer | NCT02334579 | Prostate Cancer Prostatic Cance... Prostate Neopla... Prostatic Neopl... Cancer of the P... | CyberKnife Ster... | 18 Years - | Swedish Medical Center | |
| A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma | NCT01890590 | Renal Cell Carc... | CyberKnife | 18 Years - | Dana-Farber Cancer Institute | |
| SBRT/RT in Oligometastatic Stage IV NSCLC | NCT05647590 | Non Small Cell ... | Chemotherapy Radiotherapy (R... Maintenance che... | 18 Years - 85 Years | University Hospital Ostrava | |
| Phase ǀ Study on Pancreatic Cancer Treated by CyberKnife | NCT02716207 | Pancreatic Tumo... | CyberKnife | 18 Years - 75 Years | Changhai Hospital | |
| Pulmonary Interstitial Lymphography in Early Stage Lung Cancer | NCT01188486 | Lung Cancer Lung Cancer Non... Lung Cancer Sma... Mesothelioma | Stereotactic Bo... Computed Tomogr... Cyberknife Trilogy True Beam Iohexol Iodixanol | 18 Years - | Stanford University | |
| CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry | NCT00643617 | Prostate Cancer Prostatic Cance... Prostatic Neopl... Prostate Neopla... Cancer of the P... | CyberKnife Ster... CyberKnife Ster... | 18 Years - | Accuray Incorporated | |
| Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer | NCT00840749 | Non-small Cell ... | CyberKnife Ster... Surgery | 18 Years - | Accuray Incorporated | |
| Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Radiosurgery | NCT01766492 | Prostate Cancer Localized Malig... | Stereotactic Bo... | 18 Years - 99 Years | Georgetown University | |
| Cyberknife Radiosurgery Boost for Hilar Cholangiocarcinoma (Klatskin Tumor) | NCT00630890 | Cholangiocarcin... Klatskin Tumor Biliary Tract C... | External beam r... | 18 Years - | University of California, San Francisco | |
| CyberKnife Dose Escalation Prostate Cancer Trial | NCT03822494 | Prostate Cancer Prostate Adenoc... Prostate Neopla... | CyberKnife SBRT | 18 Years - | Crozer-Keystone Health System | |
| Study on Effectiveness and Safety of Hepatocellular Carcinoma Patients Treated With CyberKnife | NCT02363218 | Liver Neoplasms | CyberKnife | 18 Years - | Tianjin Medical University Cancer Institute and Hospital | |
| CyberKnife for Unresectable Renal Tumors | NCT00807339 | Renal Cancer | Stereotactic ra... CyberKnife Robo... | 18 Years - 95 Years | Beth Israel Deaconess Medical Center | |
| CyberKnife® for Hepatic Metastases From Colorectal Cancer | NCT01318447 | Colorectal Live... | CyberKnife SBRT | 18 Years - | Accuray Incorporated |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
